ASH 2020 discussion: Looking for the best partner for lenalidomide maintenance after auto-SCT
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Multiple Myeloma Hub spoke to Francesca Gay (University of Turin, Turin, IT) and Jonathan L. Kaufman (Emory University, Atlanta, US) about the best partner for lenalidomide maintenance after autologous stem cell transplantation.
In this podcast, Kaufman and Gay discuss data from studies evaluating multiple myeloma treatment with proteasome inhibitors (bortezomib or carfilzomib) + lenalidomide. Both highlight improved progression-free survival with combination therapy vs monotherapy, particularly in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.